quinapyramine

We synthesized quinapyramine sulfate loaded-sodium alginate nanoparticles (QS-NPs) to reduce undesirable toxic effects of QS… Expand

Trypanosoma evansi infection typically produces wasting disease, but it can also develop into a neurological or… Expand

In the present article, we summarize our studies of antrycide-resistance of Trypanosoma brucei evansi in four aspects in the last… Expand

The drug sensitivities of 16 Trypanosoma evansi isolates from Sudan were examined using two different in vitro assays and rodent… Expand

Over a period of 208 days a quinapyramine-resistant population was derived in vivo from a quinapyramine-susceptible clone of… Expand

The sensitivity of three Trypanosoma equiperdum clones and thirteen Trypanosoma evansi clones originating from the People's… Expand

A Trypanosoma brucei brucei stock resistant to diminazene aceturate, isometamidium chloride, quinapyramine sulfate, and Mel B was… Expand

The drug sensitivity of seven Trypanosoma vivax-isolates from Kenya and Somalia was examined. With the exception of diminazene… Expand

Abstract A strain of T. evansi was made drug-fast to quinapyramine, suramin, stilbamidine and tryparsamide, respectively by… Expand

Homidium, quinapyramine, and suramin (Group II compounds) produce their trypanocidal effect in vivo only after a latent period of… Expand